Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Avivagen Inc VIVXF

Healthcare
Avivagen Inc. is a Canada-based life sciences company. The Company is focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports immune function, thereby supporting general health and performance. The Company’s operations as one segment, products based on OxC-beta Technology. It OxC-beta technology is derived from its discoveries about B-carotene and other carotenoids, compounds that give certain fruits and vegetables their bright colors. OxC- beta Livestock is a proprietary product, an alternative to the antibiotics commonly added to livestock feeds. The product is available for sale in the United States, Mexico, Philippines, Taiwan, New Zealand, Thailand, Australia and Malaysia. It offers OxC-beta to approximately 46.6 million food animals (poultry, swine, and dairy cattle), 133,820 dogs and 4,000 people.


GREY:VIVXF - Post by User

Avivagen Inc
Bullboard Posts
User Avatar Image
(0)
•••
Comment by gijo333on Feb 23, 2017 8:11am
234 Views
Post# 25881715

RE:RE:Avivagen Inc. Announces Results for the Quarter Ending Janua

RE:RE:Avivagen Inc. Announces Results for the Quarter Ending JanuaI'll give you guys something to pick apart. After reading this last MD&A and some research in Avivagen media website postings Here's what I understand now that we have the numbers. I'm no accountant, just "chicken feed" investor..(pardon the pun) trying to understand the big picture.
According to Avivagen media release the Unahco order of 150kg will supplement feed for 3 Million chickens. The sale reported in this last news release $65000.00 works out to 2.1 cent per chicken raised if I understand this properly. After deducting cost of goods  .7 of a cent leaves 1.4 cents per chicken. Avivagen also reported a 4 Million plus burn rate. OxC appears to sell for 433.00 per kg. with a cost  35%  leaving around 260./ kg So sales need to ramp up to around 14000  Kg per year to overcome burn rate. That's enough additive to feed 280 million chickens. As expressed in the MD&A it is imperative to secure business in many other countries to overcome the burn rate.
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities